VINEET LABORATORIES LTD (VINEETLAB) financials
VINEET LABORATORIES LTD (VINEETLAB) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Incorporated in 2003, Vineet Laboratories Ltd is in designing, developing, manufacturing of API Intermediates and Bulk Drugs
- Market Cap: ₹74.9Cr.
- Current Price: ₹39.0
- Stock P/E: 67.5
- ROE: 3.68%
- ROCE: 8.49%
- Book Value: ₹23.8
- Dividend Yield: 0.00%
- 52W High / Low: ₹43.8/28.0
In Mar 2026, VINEET LABORATORIES LTD (VINEETLAB) reported sales ₹18.89 Cr and net profit ₹0.73 Cr.
Annual Mar 2026: sales ₹59.40 Cr, net profit ₹1.11 Cr.
Shareholding: Promoters 5.98% (Jun 2026), FIIs 0.50% (Jun 2026), Public 93.52% (Jun 2026), No. of Shareholders 9,901% (Jun 2026).
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 23.86 | 18.96 | 18.10 | 14.08 | 7.44 | 17.42 | 15.65 | 18.89 |
| Expenses | 24.65 | 19.27 | 22.23 | 25.12 | 7.13 | 14.24 | 13.17 | 16.40 |
| Operating Profit | -0.79 | -0.31 | -4.13 | -11.04 | 0.31 | 3.18 | 2.48 | 2.49 |
| OPM % | -3.31% | -1.64% | -22.82% | -78.41% | 4.17% | 18.25% | 15.85% | 13.18% |
| Other Income | 0.37 | 0.20 | 0.03 | 1.38 | 0.02 | 0.01 | 0.05 | 0.03 |
| Interest | 1.14 | 0.99 | 0.95 | 0.90 | 0.61 | 2.19 | 1.09 | 0.99 |
| Depreciation | 0.61 | 0.62 | 0.62 | 0.66 | 0.63 | 0.63 | 0.63 | 0.54 |
| Profit before tax | -2.17 | -1.72 | -5.67 | -11.22 | -0.91 | 0.37 | 0.81 | 0.99 |
| Tax % | -1.84% | 6.98% | 0.53% | -6.24% | -4.40% | -8.11% | -3.70% | 27.27% |
| Net Profit | -2.13 | -1.83 | -5.71 | -10.53 | -0.87 | 0.40 | 0.85 | 0.73 |
| EPS in Rs | -1.11 | -0.95 | -2.97 | -5.48 | -0.45 | 0.21 | 0.44 | 0.38 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 243.48 | 191.10 | 212.29 | 150.59 | 75.00 | 59.40 |
| Expenses | 0.01 | 235.33 | 177.94 | 204.63 | 143.39 | 91.28 | 50.91 |
| Operating Profit | -0.01 | 8.15 | 13.16 | 7.66 | 7.20 | -16.28 | 8.49 |
| OPM % | — | 3.35% | 6.89% | 3.61% | 4.78% | -21.71% | 14.29% |
| Other Income | 0.00 | 0.39 | 0.29 | 0.12 | 0.46 | 1.99 | 0.10 |
| Interest | 0.00 | 2.67 | 2.09 | 3.38 | 4.78 | 3.98 | 4.89 |
| Depreciation | 0.00 | 1.81 | 2.02 | 2.37 | 2.52 | 2.50 | 2.41 |
| Profit before tax | -0.01 | 4.06 | 9.34 | 2.03 | 0.36 | -20.77 | 1.29 |
| Tax % | 0.00% | 56.16% | 28.91% | 38.42% | -183.33% | -2.79% | 13.18% |
| Net Profit | -0.01 | 1.78 | 6.64 | 1.25 | 1.03 | -20.19 | 1.11 |
| EPS in Rs | -0.11 | 0.93 | 3.46 | 0.65 | 0.54 | -10.52 | 0.58 |
| Dividend Payout % | 0.00% | 0.00% | 13.89% | 0.00% | 0.00% | 0.00% | 0.00% |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.41 | 9.22 | 9.22 | 9.22 | 9.22 | 9.22 | 19.21 |
| Reserves | -0.01 | 17.40 | 24.00 | 24.46 | 25.51 | 5.43 | 26.40 |
| Borrowings | 0.00 | 12.48 | 26.51 | 31.09 | 44.30 | 40.05 | 45.33 |
| Other Liabilities | 0.00 | 69.64 | 73.59 | 51.08 | 37.84 | 39.84 | 33.84 |
| Total Liabilities | 0.40 | 108.74 | 133.32 | 115.85 | 116.87 | 94.54 | 124.78 |
| Fixed Assets | 0.00 | 19.67 | 21.38 | 26.65 | 26.92 | 25.46 | 24.24 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.12 | 0.14 | 0.13 | 0.18 | 0.21 | 0.19 |
| Other Assets | 0.40 | 88.95 | 111.80 | 89.07 | 89.77 | 68.87 | 100.35 |
| Total Assets | 0.40 | 108.74 | 133.32 | 115.85 | 116.87 | 94.54 | 124.78 |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 0.00 | 27.49 | 7.63 | -9.62 | -6.61 | 11.49 | -12.03 |
| Cash from Investing Activity | 0.00 | -7.81 | -3.68 | -6.69 | -2.22 | -3.18 | -1.11 |
| Cash from Financing Activity | 0.00 | 18.62 | 11.96 | 0.27 | 8.43 | -8.23 | 29.74 |
| Net Cash Flow | 0.00 | 38.30 | 15.91 | -16.03 | -0.40 | 0.08 | 16.60 |
| Free Cash Flow | 0.00 | 27.49 | 7.63 | -17.25 | -9.40 | 10.44 | -13.23 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 0% | 327% | 82% | -87% | -88% | -71% | -144% |
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 36.07% | 35.85% | 35.85% | 29.26% | 15.89% | 12.46% | 5.98% | 5.98% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.36% | 0.50% |
| Public | 63.93% | 64.15% | 64.15% | 70.74% | 84.11% | 87.54% | 93.67% | 93.52% |
| No. of Shareholders | 10,300 | 10,058 | 10,025 | 9,988 | 9,682 | 10,003 | 9,929 | 9,901 |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | — | 64.03 | 69.14 | 60.45 | 76.59 | 64.48 | 70.05 |
| Inventory Days | — | 73.12 | 109.19 | 97.79 | 158.26 | 259.67 | 606.03 |
| Days Payable | — | 114.08 | 161.20 | 73.90 | 103.37 | 174.65 | 239.52 |
| Cash Conversion Cycle | — | 23.07 | 17.13 | 84.34 | 131.48 | 149.50 | 436.56 |
| Working Capital Days | — | 14.41 | -19.46 | 20.63 | 28.48 | -37.28 | 88.98 |
| ROCE % | — | 34.08% | 23.13% | 8.69% | 6.65% | -27.95% | 8.49% |
Vineet Laboratories Ltd
₹74.9Cr.
₹39.0
₹43.8/28.0
67.5
Incorporated in 2003, Vineet Laboratories Ltd is in designing, developing, manufacturing of API Intermediates and Bulk Drugs
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of VINEET LABORATORIES LTD (VINEETLAB)?
The reported market capitalisation for VINEET LABORATORIES LTD (VINEETLAB) is ₹74.9Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of VINEETLAB?
The current price shown for VINEET LABORATORIES LTD (VINEETLAB) on Fincrux is ₹39.0 with a 52-week high/low of ₹43.8/28.0.
What is the P/E ratio of VINEET LABORATORIES LTD (VINEETLAB)?
The stock P/E for VINEET LABORATORIES LTD (VINEETLAB) is 67.5 on Fincrux, with ROE at 3.68% and ROCE at 8.49%.
What were VINEETLAB latest quarterly results?
For Mar 2026, VINEET LABORATORIES LTD (VINEETLAB) reported sales ₹18.89 Cr and net profit ₹0.73 Cr (figures in ₹ crore unless noted).
What are VINEETLAB annual sales and net profit?
For Mar 2026, VINEET LABORATORIES LTD (VINEETLAB) shows sales of ₹59.40 Cr and net profit of ₹1.11 Cr on the Fincrux profit & loss statement.
Who owns VINEET LABORATORIES LTD (VINEETLAB)?
Latest shareholding for VINEET LABORATORIES LTD (VINEETLAB) on Fincrux: Promoters 5.98% (Jun 2026), FIIs 0.50% (Jun 2026), Public 93.52% (Jun 2026), No. of Shareholders 9,901% (Jun 2026).
Where can I find VINEET LABORATORIES LTD (VINEETLAB) financials?
VINEET LABORATORIES LTD (VINEETLAB) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show VINEETLAB balance sheet and cash flow?
Yes. The VINEET LABORATORIES LTD (VINEETLAB) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.